(Q35017644)

5 August 2017

1 reference

title

Oxidative mechanisms and tardive dyskinesia (English)

1 reference

5 August 2017

1 reference

3

Alexander B Niculescu

1 reference

5 August 2017

2

Ronald Kuczenski

1 reference

5 August 2017

James B Lohr

1

1 reference

5 August 2017

language of work or name

1 reference

1 January 2003

1 reference

5 August 2017

1 reference

5 August 2017

volume

17

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

47-62

1 reference

Oxidative stress, metabolism of ethanol and alcohol-related diseases

5 August 2017

cites work

1 reference

12 December 2020

Antioxidants, oxidative stress, and degenerative neurological disorders

1 reference

12 December 2020

Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

1 reference

12 December 2020

Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

1 reference

12 December 2020

Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia

1 reference

12 December 2020

A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.

1 reference

12 December 2020

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

12 December 2020

The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study

1 reference

12 December 2020

Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia

1 reference

12 December 2020

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

1 reference

12 December 2020

Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia

1 reference

12 December 2020

Induction of reactive oxygen species in neurons by haloperidol.

1 reference

12 December 2020

Neuroleptic-induced mitochondrial enzyme alterations in the rat brain.

1 reference

12 December 2020

Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.

1 reference

12 December 2020

The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects

1 reference

12 December 2020

Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis.

1 reference

12 December 2020

Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration.

1 reference

12 December 2020

Free radicals as mediators of alcohol toxicity

1 reference

12 December 2020

Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics

1 reference

12 December 2020

The treatment of tardive dyskinesia--a systematic review and meta-analysis

1 reference

12 December 2020

Oxidative stress induced by administration of the neuroleptic drug haloperidol is attenuated by higher doses of haloperidol

1 reference

12 December 2020

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

12 December 2020

Chronic treatment with prolixin causes oxidative stress in rat brain.

1 reference

12 December 2020

Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity

1 reference

12 December 2020

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1 reference

12 December 2020

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

1 reference

12 December 2020

Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines

1 reference

12 December 2020

Reduced level of plasma antioxidant uric acid in schizophrenia.

1 reference

12 December 2020

Tardive dyskinesia and substrates of energy metabolism in CSF.

1 reference

12 December 2020

Long-term treatment effects of vitamin E for tardive dyskinesia

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms

1 reference

12 December 2020

Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation

1 reference

12 December 2020

Neuroleptic-induced striatal damage in rats: a study of antioxidant treatment using accelerometric and immunocytochemical methods

1 reference

12 December 2020

1 reference

12 December 2020

An experimental model of tardive dyskinesia

1 reference

12 December 2020

A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia.

1 reference

12 December 2020

Reactive oxygen species and protein oxidation in aging: a look back, a look ahead

1 reference

12 December 2020

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia

1 reference

12 December 2020

Withdrawal-associated changes in peripheral nitrogen oxides and striatal cyclic GMP after chronic haloperidol treatment

1 reference

12 December 2020

Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.

1 reference

12 December 2020

Oxidative damage in neurodegenerative disease

1 reference

12 December 2020

Ageing and the free radical theory

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study

1 reference

12 December 2020

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations

1 reference

12 December 2020

Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients

1 reference

12 December 2020

alpha-Tocopherol treatment for tardive dyskinesia

1 reference

12 December 2020

Iron pigment in the brain of a man with tardive dyskinesia

1 reference

12 December 2020

Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Treatment of tardive dyskinesia with vitamin E.

1 reference

12 December 2020

Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs

1 reference

12 December 2020

Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice

1 reference

12 December 2020

Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients

1 reference

12 December 2020

Estrogen receptor activation and tardive dyskinesia

1 reference

12 December 2020

Staining intensity of brain iron in patients with schizophrenia: a postmortem study

1 reference

12 December 2020

Effect of chlorphromazine on central nervous system concentrations of manganese, iron, and copper

1 reference

12 December 2020

Vitamin E treatment of tardive dyskinesia

1 reference

12 December 2020

The current status of tardive dyskinesia.

1 reference

12 December 2020

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

12 December 2020

MRI in tardive dyskinesia: shortened left caudate T2.

1 reference

12 December 2020

Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

1 reference

12 December 2020

Does vitamin E prevent tardive dyskinesia?

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia

1 reference

12 December 2020

Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment

1 reference

12 December 2020

Haloperidol-induced cell death--mechanism and protection with vitamin E in vitro.

1 reference

12 December 2020

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

12 December 2020

The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia

1 reference

12 December 2020

Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication

1 reference

12 December 2020

Whither vitamin E and tardive dyskinesia?

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia

1 reference

12 December 2020

Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia: a replication study

1 reference

12 December 2020

Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease

1 reference

12 December 2020

Oxidative stress evaluation in diabetes

1 reference

12 December 2020

Expected incidence of tardive dyskinesia associated with atypical antipsychotics.

1 reference

12 December 2020

Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia

1 reference

12 December 2020

Melatonin, mitochondria, and cellular bioenergetics

1 reference

12 December 2020

Clozapine withdrawal-emergent dystonias and dyskinesias: a case series

1 reference

12 December 2020

Research Diagnoses for Tardive Dyskinesia

1 reference

12 December 2020

Amphiphilic alpha-tocopherol analogues as inhibitors of brain lipid peroxidation.

1 reference

12 December 2020

Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.

1 reference

12 December 2020

Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth

1 reference

12 December 2020

Effectiveness of vitamin E for treatment of long-term tardive dyskinesia

1 reference

12 December 2020

Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study

1 reference

12 December 2020

Neuroleptic medications inhibit complex I of the electron transport chain

1 reference

12 December 2020

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

1 reference

12 December 2020

Treatment of long-term tardive dyskinesia with vitamin E.

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses

1 reference

12 December 2020

Haloperidol-induced neurotoxicity--possible implications for tardive dyskinesia

1 reference

12 December 2020

Alpha-tocopherol in tardive dyskinesia

1 reference

12 December 2020

10.2165/00023210-200317010-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1028830768

0 references

1 reference